Skip to main content
Veterinary Medicines

ReVet RV 18

Authorised
  • Berberis vulgaris C4
  • LYTTA VESICATORIA C6
  • LYCOPODIUM CLAVATUM C9
  • Sabal serrulata C4

Product identification

Medicine name:
ReVet RV 18
Active substance:
  • Berberis vulgaris C4
  • LYTTA VESICATORIA C6
  • LYCOPODIUM CLAVATUM C9
  • Sabal serrulata C4
Target species:
  • Pigeon
  • Turkey
  • Cattle
  • Amphibians
  • Reptile
  • Chicken
  • Duck
  • Goose
  • Ornamental bird
  • Dog
  • Goat
  • Sheep
  • Horse
  • Cat
  • Rabbit
  • Guinea pig
  • Mouse
  • Rat
  • Pig
  • Carp
  • Trout
  • Marten
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Berberis vulgaris C4
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • LYTTA VESICATORIA C6
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • LYCOPODIUM CLAVATUM C9
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • Sabal serrulata C4
    2.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Pillules
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Homeopathic Registration
Marketing authorisation holder:
  • Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402335.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."